
Adaptive Biotechnologies
Leveraging the adaptive immune system to diagnose and treat disease.
About
Adaptive Biotechnologies harnesses the adaptive immune system to power the Age of Immune Medicine, translating immune system genetics into actionable data. Their core offerings include clonoSEQ for Measurable Residual Disease assessment and an Immune Medicine Platform that informs clinical trials and the development of transformative medicines. They serve clinicians, biopharma companies, and patients by transforming how diseases are detected, monitored, and treated.
Also in this space
AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.
Shares Biotech, Drug Discovery
Develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need.
Shares Diagnostics, HealthTech
A global oncology company developing and commercializing innovative cancer treatments.
Shares Biotech, HealthTech
Developing engineered biologics to harness the immune system for disease treatment.
Shares Biotech, Drug Discovery
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
Shares Biotech, HealthTech
Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
Shares Biotech, HealthTech
Key facts
- Website
- adaptivebiotech.com
- Headquarters
- Seattle, United States
- Founded
- 2009
- Total funding
- $300M (Series D)
- Business model
- B2B
Funding rounds
Tech stack
Detected on adaptivebiotech.com, last scanned 1 Nov 2026. Run your own scan
- Compliance
- HIPAA
- Frontend
- jQuery
- Auth
- Auth0
- Analytics
- Google Tag Manager
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- Email provider
- Cisco IronPort, Google Workspace
- Email marketing
- Mailgun
Adaptive Biotechnologies scores 63. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Adaptive Biotechnologies trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Adaptive Biotechnologies is 89 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Adaptive Biotechnologies raised?
Adaptive Biotechnologies has raised a total of $300M in funding. The most recent round on record is Series D.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Adaptive Biotechnologies


